Outcomes in 11 patients with dermatofibrosarcoma protuberans treated with Mohs micrographic surgery

International Journal of Dermatology

Volumn 51, Issue 1, 2012, Pages 89-93

  Galimberti, Gastón ^a   Montaño, Anahí Pontón ^a   Kowalczuk, Alicia ^a   Ferrario, Damian ^a   Galimberti, Ricardo ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CHEMOSURGERY; CLINICAL ARTICLE; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HUMAN; MALE; METASTASIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DERMATOFIBROSARCOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; MOHS SURGERY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84055189191     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04721.x     Document Type: Article

References (26)

1. Gloster H. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996; 35: 355-374.
2. Browne W, Antonescu C, Leung D, et al. Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer 2000; 88: 2711-2720.
3. Smola M, Soyer H, Scharnagl E. Surgical treatment of dermatofibrosarcoma protuberans: a retrospective study of 20 cases with review of the literature. Eur J Surg Oncol 1991; 17: 447-453.
4. Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 2003; 37: 1-19.
5. Takahira T, Oda Y, Tamiya S, et al. Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans. Mod Pathol 2007; 20: 668-675.
6. Wrotnowski V, Cooper PH, Shmookler BM. Fibrosarcomatous change in dermatofibrosarcoma protuberans. Am J Surg Pathol 1988; 12: 287-293.
7. Rademaker B, Angelillo M, Reiman H, et al. Dermatofibrosarcoma protuberans: a review of 73 cases. Eur J Plast Surg 1990; 13: 251-255.
8. Chang C, Jacobs I, Salti G. Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol 2004; 30: 341-345.
9. Gloster H, Harris K, Roenigk R. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996; 35: 82-87.
10. Ratner D, Thomas C, Johnson T, et al. Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of multi-institutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol 1997; 37: 600-613.
11. Tom W, Hybarger C, Rasgon B. Dermatofibrosarcoma protuberans of the head and neck: treatment with Mohs surgery using inverted horizontal paraffin sections. Laryngoscope 2003; 113: 1289-1293.
12. Snow S, Gordon E, Larson P, et al. Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with longterm follow-up and review of the literature. Cancer 2004; 101: 28-38.
13. Haycox C, Odland P, Olbricht S, et al. Dermatofibrosarcoma protuberans: growth characteristics based on modeling and a review of cases treated with Mohs micrographic surgery. Ann Plast Surg 1997; 38: 246-251.
14. Jimenez F, Grichnik J, Buchanan M, et al. Immunohistochemical margin control applied to Mohs micrographic surgical excision of dermatofibrosarcoma protuberans. J Dermatol Surg Oncol 1994; 20: 687-689.
15. Haycox C, Odland P, Olbricht S, et al. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J Am Acad Dermatol 1997; 37: 438-444.
16. Buchdunger E, O'Reilly T, Wood J. Pharmacology of imatinib (STI571). Eur J Cancer 2002; 38(Suppl. 5): 28-36.
17. Manley PW, Cowan-Jacob SW, Buchdunger E, et al. Imatinib: a selective tyrosine kinase inhibitor. Eur J Cancer 2002; 38(Suppl. 5): 19-27.
18. Greco A, Roccato E, Miranda C, et al. Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement. Int J Cancer 2001; 92: 354-360.
19. Maki RG, Awan RA, Dixon RH, et al. Differential sensitivity to imatinib of two patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int J Cancer 2002; 100: 623-626.
20. Rutkowski P, van Glabbeke M, Rankin C, et al. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials. J Clin Oncol 2010; 1772-1779.
21. Han A, Chen E, Niedt G, et al. Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans. Arch Dermatol 2009; 145: 792-796.
22. Breuninger H, Schaumburg-Lever G. Control of excisional margins by conventional histopathological techniques in the treatment of skin tumors. An alternative to Moh's technique. J Pathol 1988; 154: 167-171.
23. Gattoni M, Tiberio R, Angeli L, et al. Dermatofibrosarcoma protuberans: surgical treatment using the Tübingen technique (31 cases). Ann Dermatol Venereol 2007; 134: 31-34.
24. Wacker J, Khan-Durani B, Hartschuh W. Modified Mohs micrographic surgery in the therapy of dermatofibrosarcoma protuberans: analysis of 22 patients. Ann Surg Oncol 2004; 11: 438-444.
25. Hafner J, Schutz K, Morgenthaler W, et al. Micrographic surgery ("slow Mohs") in cutaneous sarcomas. Dermatology 1999; 198: 37-43.
26. DuBay D, Cimmino V, Lowe L, et al. Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer 2004; 100: 1008-1016.